Stewart A Factor Selected Research

Stewart A Factor Research Topics

Disease

41	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2002
16	Tardive Dyskinesia 01/2022 - 04/2009
14	Parkinsonian Disorders (Parkinsonism) 01/2022 - 12/2006
11	Movement Disorders (Movement Disorder) 01/2022 - 04/2008
10	Dyskinesias (Dyskinesia) 01/2022 - 10/2004
8	Dystonia (Limb Dystonia) 01/2022 - 01/2002
8	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 07/2002
5	Torticollis (Wryneck) 01/2021 - 12/2003
4	Psychomotor Agitation (Akathisia) 01/2022 - 06/2011
4	Dementia (Dementias) 11/2018 - 07/2002
4	Schizophrenia (Dementia Praecox) 11/2017 - 10/2004
3	Tremor (Tremors) 01/2022 - 10/2004
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 11/2014
3	Mood Disorders (Mood Disorder) 11/2017 - 01/2014
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2012
2	Sleepiness 01/2020 - 12/2009
2	Cognitive Dysfunction 11/2018 - 01/2012
2	Inflammation (Inflammations) 01/2018 - 08/2014
2	Deglutition Disorders (Dysphagia) 01/2018 - 08/2010
2	Huntington Disease (Huntington's Disease) 01/2017 - 07/2016
2	Migraine Disorders (Migraine) 10/2014 - 06/2011
2	Hyperthermia 05/2011 - 01/2007
2	Pain (Aches) 12/2009 - 03/2004
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Nausea 01/2020
1	Drug-Induced Akathisia (Akathisia, Drug Induced) 09/2019
1	Hyperkinesis 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2016
1	Hypotension (Low Blood Pressure) 11/2016
1	Chorea (Rheumatic Chorea) 07/2016
1	Hallucinations (Hallucination) 12/2014
1	Nervous System Diseases (Neurological Disorders) 08/2013
1	Confusion (Bewilderment) 08/2013
1	Drug-Induced Dyskinesia (Dyskinesia, Drug Induced) 08/2013
1	Narcolepsy 01/2013
1	Seizures (Absence Seizure) 12/2012
1	Craniocerebral Trauma (Head Injury) 01/2012
1	Blepharospasm 06/2011

Drug/Important Bio-Agent (IBA)

15	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 12/2003
14	Pharmaceutical PreparationsIBA 01/2022 - 07/2002
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 01/2014
8	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 01/2008
6	deutetrabenazineIBA 01/2022 - 07/2016
4	alpha-SynucleinIBA 08/2021 - 04/2008
4	valbenazineIBA 01/2019 - 10/2015
4	Coffee FDA Link 11/2014 - 01/2008
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 08/2013
3	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	neuromelaninIBA 01/2017 - 12/2014
3	Dopamine (Intropin)FDA LinkGeneric 01/2012 - 01/2006
3	Botulinum Toxins (Botulinum Toxin)IBA 06/2011 - 07/2009
2	AntiemeticsIBA 01/2022 - 01/2014
2	LithiumIBA 01/2022 - 12/2016
2	Clozapine (Clozaril)FDA LinkGeneric 10/2020 - 10/2004
2	Apomorphine FDA Link 01/2020 - 03/2004
2	Propranolol (Inderal)FDA LinkGeneric 11/2016 - 11/2012
2	Glutamate Receptors (Glutamate Receptor)IBA 11/2014 - 08/2011
2	Metoclopramide (Reglan)FDA LinkGeneric 10/2014 - 01/2014
2	SynucleinsIBA 08/2014 - 01/2012
2	PesticidesIBA 10/2011 - 09/2009
2	Aripiprazole (Abilify)FDA Link 04/2009 - 12/2006
2	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2003 - 01/2002
1	Excipients (Suspending Agents)IBA 01/2022
1	Biological ProductsIBA 01/2021
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2019
1	Cytochrome P-450 CYP2D6 InhibitorsIBA 12/2019
1	Lurasidone Hydrochloride FDA Link 09/2019
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2019
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018
1	Cholinergic Agents (Cholinergics)IBA 11/2018
1	pimavanserinIBA 11/2018
1	C-Reactive ProteinIBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	abobotulinumtoxinA FDA Link 01/2018
1	coenzyme Q10 (CoQ10)IBA 01/2017
1	Sigma-1 ReceptorIBA 01/2017
1	Dopamine AntagonistsIBA 01/2017
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2017
1	Quinidine (Chinidin)FDA LinkGeneric 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 11/2014
1	KetorolacIBA 10/2014
1	peptidoglycan recognition proteinIBA 08/2014
1	dimemorfan (AT 17)IBA 01/2014
1	Adenosine (Adenocard)FDA LinkGeneric 06/2013
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 06/2013
1	OrexinsIBA 01/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2012
1	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 10/2011
1	salicylhydroxamic acid (SHAM)IBA 08/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2002
6	Deep Brain Stimulation 01/2022 - 01/2007
3	Injections 06/2011 - 01/2002
1	Drug Therapy (Chemotherapy) 04/2020
1	Home Nursing (Nursing, Home) 12/2014